Master the board step 3

Index
Placenta
abruptio placenta, 423, 425
accreta, 424–25
previa, 424–25
Plantar fasciitis, 157, 344
Plasma cell disorders, 178–80
Platelet disorders
inhibition, acute coronary
syndrome, 51–52
uremia-induced platelet
dysfunction, 184
Von Willebrand’s disease, 182
Platelet therapy, 261
Pleural effusion, 126–27, 489
Pleurodesis, 126
Plummer-Vinson syndrome, 189
Pneumatosis intestinalis, 364
Pneumococcal vaccine, 286–87
Pneumocystis jiroveci pneumonia
(PCP), 32
Pneumomediastinum, 489
Pneumonia, 129–31, 359
imaging studies, 490
in newborn, 368
in pediatric patient, 384–85
vaccine, 286–87
Pneumoperitoneum, 316–17, 489
Pneumothorax
imaging, 489
tension pneumothorax, 310,
332
Polyarteritis nodosa (PAN), 151,
214, 257–58
Polycystic kidney disease, 402
Polycystic ovary syndrome
(PCOS), 111, 463, 477–79
Polycythemia vera (Pvera), 178
Polyhydramnios, 363
Polymyalgia rheumatica (PMR),
149–50
Polymyositis (PM), 147–48
Polysomnography, 127
Popliteal artery injuries, 341
Porphyria cutanea tarda (PCT),
291
Port wine stain, 355
Positive-end expiratory pressure
(PEEP), 129
Posterior dislocation, 339
Postmenopausal bleeding, 463
Postoperative complications,
329–32
Postpartum period
contraception, 453
depression, 509
fever, 454
hemorrhage, 452–53
Postrenal azotemia, 252
Post-streptococcal
glomuleronephritis (PSGN), 259
Posttraumatic stress disorder
(PTSD), 504–5
Potassium disorders, 227
Prader-Willi syndrome, 373
Prasugrel, 51–54
Preauricular tags/pits, 356
Preeclampsia, 433–35
Pregnancy
acyclovir in, 21
antibiotics in, 19–20
cervical cancer in, 469–70
diagnosis, 417
diverticulitis and, 320
ectopic pregnancy, 20
ethics in, 543
HIV/AIDS and, 31
hypertension in, 433–36
medical complications in,
436–40
mitral stenosis, 74–75
molar pregnancy, 484–85
perinatal infections, 425–33
prenatal screening, 417–19
termination of, 440–43
third trimester bleeding,
422–23
uncomplicated, 417–22
Premature rupture of membranes
(PROM), 446–47
Premenstrual dysphoric disorder
(PMDD), 477
Premenstrual tension, 477
Prenatal care
first trimester, 417–19
HIV/AIDS and, 31
screening tests, 417–19
second trimester, 420
third trimester screening,
421–22
Preoperative assessment, 327–29
Prerenal azotemia, 251–52
Primary angioplasty, 52
Primary biliary cirrhosis (PBC),
219
Primary immunodeficiency
syndromes, 42–43
Primary renal disorders, 262
Primary sclerosis cholangitis
(PSC), 219
Primiparas, 434
Primum computer-based case
simulations format, xvii
Prinzmetal’s variant angina, 189
Procainamide, 85
Progestins, 463
Progressive multifocal
leukoencephalopathy (PML),
33, 242
Progressive systemic sclerosis,
189–90
Prolactinoma, 109, 456
Prophylaxis
HIV/AIDS, 31–33
infective endocarditis, 29
malaria, 36
Propranolol, 108, 218
Propylthiouracil (PTU), 98
Prostate cancer, 281–82
screening, 286
Prostatitis, 26
Protease inhibitors, 30–31
Protein C deficiency, 186
Proteinuria, 262–63
pediatric patients, 402–3
Prothrombin gene mutation, 437
Proton pump inhibitors (PPI),
191–92
Pseudogout, 153, 155
563